NI
ATYR

Numeric Investors’s aTyr Pharma ATYR Stock Holding History

Numeric Investors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-890
Closed -$122K – 1150
2015
Q4 		$122K Buy
890
+122
+16% +$17.4K ﹤0.01% 945
2015
Q3 		$110K Buy
+768
New +$175K ﹤0.01% 953

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Numeric Investors's ATYR Position: Q1 2016 in Review

Numeric Investors sold out of aTyr Pharma (ATYR) in Q1 2016, closing a stake of 890 shares — an estimated $122K sold.

Numeric Investors first reported a position in ATYR in Q3 2015 and held it in 2 quarters. The position peaked at $122K in Q4 2015. 50 funds tracked by Wall St. Rank hold ATYR as of Q1 2016.

  • Numeric Investors reported no remaining aTyr Pharma position as of Q1 2016 after selling out during the quarter.
  • Numeric Investors sold 890 aTyr Pharma shares in Q1 2016, an estimated $122K.
  • Numeric Investors first reported a position in aTyr Pharma in Q3 2015 and held it in 2 quarters.
  • Numeric Investors's aTyr Pharma position peaked at $122K in Q4 2015.
  • 50 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2016.

Based on Numeric Investors's 13F filing for Q1 2016, filed 6 May 2016.